Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BUPROPION HYDROCHLORIDE USP, with a corresponding US DMF Number 20210.
Remarkably, this DMF maintains an Active status since its submission on January 23, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 27, 2018, and payment made on September 21, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II